Viking Therapeutics (VKTX) Tops Q2 EPS by 6c

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.20), $0.06 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Viking Therapeutic (VKTX) PT Raised to $87 at Truist Securities
• McDonald's (MCD) Said August In Us Business Was 'slightly Negative' - Bloomberg
• Paychex (PAYX) Tops Q1 EPS by 2c